Submitted by admin on September 11, 2024 - 11:58am
Roche ramps up R&D with $1.4B Swiss facility
Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial
GSK's experimental herpes vaccine fails to meet main goal in trial
3 FDA approval dates to watch in the year’s final push
*please scroll down for all the latest news*
